We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Roche’s Arthritis Drug Reduces COVID-19 Deaths in UK Trial
Roche’s Arthritis Drug Reduces COVID-19 Deaths in UK Trial
Roche’s anti-inflammatory drug Actemra (tocilizumab) has been shown to reduce COVID-19-related deaths in the UK’s RECOVERY trial of multiple potential treatments.